Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices 36749 

1We note that the Citizen’s Advisory Panel on 

Medicare Education is also referred to as the 

Advisory Panel on Medicare Education (65 FR 

4617). The name was updated in the Second 

Amended Charter approved on July 24, 2000. 

and (II) full Technical Report and 

Appendixes. 

The purpose of the public comment 

period is to obtain comments on the 

draft report. Comments are being sought 

from individuals including scientists 

and representatives from various 

government agencies, industry, labor, 

and other stakeholders, and also the 

public. If there are errors of fact, 

unsubstantiated claims, evidence of 

careless experimental work, inclusion of 

too much information already in the 

literature, or statements that are 

inaccurate, please note such in your 

review comments. 

The authors ask that special emphasis 

be placed on technical review of the 

following issues: 

1. Does the draft document adequately 

describe the process for gathering and 

evaluating the information available on 

occupational exposure limits or bands 

for engineered nanomaterials? 

2. Does the draft document adequately 

describe the development of a 

framework for categorizing engineered 

nanomaterials by potential occupational 

health hazard from inhalation exposure? 

3. Are the clustering and classification 

modeling methodologies reasonable for 

these data? 

4. Is a revision to current occupational 

exposure banding guidance needed to 

incorporate a band F? 

5. How useful and practical is the 

approach described in both the user 

guide and full technical report for 

deriving categorical occupational 

exposure limits, and what are the 

opportunities for improvement? 

6. Are the current searches and 

collection of scientific data sufficient, 

and are there additional opportunities 

for obtaining data that were not 

included? 

7. Would the methods used in the 

report also be appropriate for a future 

comprehensive dataset of experimental, 

toxicological, and physicochemical 

information for engineered 

nanomaterials? 

8. Are there additional comments that 

you would like to provide? 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2021–14801 Filed 7–12–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7063–N] 

Announcement of the Advisory Panel 

on Outreach and Education (APOE) 

July 28, 2021 Virtual Meeting 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces the 

next meeting of the APOE (the Panel) in 

accordance with the Federal Advisory 

Committee Act. The Panel advises and 

makes recommendations to the 

Secretary of the U.S. Department of 

Health and Human Services (HHS) (the 

Secretary) and the Administrator of the 

Centers for Medicare & Medicaid 

Services (CMS) on opportunities to 

enhance the effectiveness of consumer 

education strategies concerning the 

Health Insurance Marketplace®, 

Medicare, Medicaid, and the Children’s 

Health Insurance Program (CHIP). This 

meeting is open to the public. 

DATES: 

Meeting Date: Wednesday, July 28, 

2021 from 12:00 p.m. to 5:00 p.m. 

eastern daylight time (e.d.t). 

Deadline for Meeting Registration, 

Presentations, Special 

Accommodations, and Comments: 

Wednesday, July 14, 2021, 5:00 p.m. 

(e.d.t). 

ADDRESSES: 

Meeting Location: Virtual. All those 

who RSVP will receive the link to 

attend. 

Presentations and Written Comments: 

Presentations and written comments 

should be submitted to: Lisa Carr, 

Designated Federal Official (DFO), 

Office of Communications, Centers for 

Medicare & Medicaid Services, 200 

Independence Avenue SW, Mailstop 

325G HHH, Washington, DC 20201, 

202–690–5742, or via email at APOE@

cms.hhs.gov. 

Registration: The meeting is open to 

the public, but attendance is limited to 

the space available. Persons wishing to 

attend this meeting must register at the 

website https://www.eventbrite.com/e/ 

apoe-july-28-2021-virtual-meetingtickets-151112584809 or by contacting 

the DFO listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice, by the date listed in the DATES

section of this notice. Individuals 

requiring sign language interpretation or 

other special accommodations should 

contact the DFO at the address listed in 

the ADDRESSES section of this notice by 

the date listed in the DATES section of 

this notice. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Carr, Designated Federal Official, Office 

of Communications, 200 Independence 

Avenue SW, Mailstop 325G HHH, 

Washington, DC 20201, 202–690–5742, 

or via email at APOE@cms.hhs.gov. 

Additional information about the 

APOE is available at: https://

www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press 

inquiries are handled through the CMS 

Press Office at (202) 690–6145. 

SUPPLEMENTARY INFORMATION: 

I. Background and Charter Renewal 

Information 

A. Background 

The Advisory Panel for Outreach and 

Education (APOE) (the Panel) is 

governed by the provisions of the 

Federal Advisory Committee Act 

(FACA) (Pub. L. 92–463), as amended (5 

U.S.C. Appendix 2), which sets forth 

standards for the formation and use of 

federal advisory committees. The Panel 

is authorized by section 1114(f) of the 

Social Security Act (the Act) (42 U.S.C. 

1314(f)) and section 222 of the Public 

Health Service Act (42 U.S.C. 217a). 

The Secretary of the U.S. Department 

of Health and Human Services (HHS) 

(the Secretary) signed the charter 

establishing the Citizen’s Advisory 

Panel on Medicare Education 1 (the 

predecessor to the APOE) on January 21, 

1999 (64 FR 7899) to advise and make 

recommendations to the Secretary and 

the Administrator of the Centers for 

Medicare & Medicaid Services (CMS) on 

the effective implementation of national 

Medicare education programs, including 

with respect to the Medicare+Choice 

(M+C) program added by the Balanced 

Budget Act of 1997 (Pub. L. 105–33). 

The Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 (MMA) (Pub. L. 108–173) 

expanded the existing health plan 

options and benefits available under the 

M+C program and renamed it the 

Medicare Advantage (MA) program. 

CMS has had substantial responsibilities 

to provide information to Medicare 

beneficiaries about the range of health 

plan options available and better tools 

to evaluate these options. The 

successful MA program implementation 

required CMS to consider the views and 

policy input from a variety of private 


jbell on DSKJLSW7X2PROD with NOTICES
36750 Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices 

2Health Insurance Marketplace®SM and 

Marketplace®SM are service marks of the U.S. 

Department of Health and Human Services. 

sector constituents and to develop a 

broad range of public-private 

partnerships. 

In addition, Title I of the MMA 

authorized the Secretary and the 

Administrator of CMS (by delegation) to 

establish the Medicare prescription drug 

benefit. The drug benefit allows 

beneficiaries to obtain qualified 

prescription drug coverage. In order to 

effectively administer the MA program 

and the Medicare prescription drug 

benefit, we have substantial 

responsibilities to provide information 

to Medicare beneficiaries about the 

range of health plan options and 

benefits available, and to develop better 

tools to evaluate these plans and 

benefits. 

The Patient Protection and Affordable 

Care Act (Pub. L. 111–148) and Health 

Care and Education Reconciliation Act 

of 2010 (Pub. L. 111–152) (collectively 

referred to as the Affordable Care Act) 

expanded the availability of other 

options for health care coverage and 

enacted a number of changes to 

Medicare as well as to Medicaid and 

CHIP. Qualified individuals and 

qualified employers are now able to 

purchase private health insurance 

coverage through a competitive 

marketplace, called an Affordable 

Insurance Exchange (also called Health 

Insurance Marketplace®, or 

Marketplace® 2). In order to effectively 

implement and administer these 

changes, we must provide information 

to consumers, providers, and other 

stakeholders through education and 

outreach programs regarding how 

existing programs will change and the 

expanded range of health coverage 

options available, including private 

health insurance coverage through the 

Marketplace®. The APOE (the Panel) 

allows us to consider a broad range of 

views and information from interested 

audiences in connection with this effort 

and to identify opportunities to enhance 

the effectiveness of education strategies 

concerning the Affordable Care Act. 

The scope of this Panel also includes 

advising on issues pertaining to the 

education of providers and stakeholders 

with respect to the Affordable Care Act 

and certain provisions of the Health 

Information Technology for Economic 

and Clinical Health (HITECH) Act 

enacted as part of the American 

Recovery and Reinvestment Act of 2009 

(ARRA) (Pub. L. 111–5). 

On January 21, 2011, the Panel’s 

charter was renewed and the Panel was 

renamed the Advisory Panel for 

Outreach and Education. The Panel’s 

charter was most recently renewed on 

January 19, 2021, and will terminate on 

January 19, 2023 unless renewed by 

appropriate action. 

B. Charter Renewal 

In accordance with the January 19, 

2021, charter, the APOE will advise the 

HHS and CMS on developing and 

implementing education programs that 

support individuals who are enrolled in 

or eligible for Medicare, Medicaid, 

CHIP, or coverage available through the 

Health Insurance Marketplace® and 

other CMS programs. The scope of this 

FACA group also includes advising on 

education of providers and stakeholders 

with respect to health care reform and 

certain provisions of the HITECH Act 

enacted as part of the ARRA. 

The charter will terminate on January 

19, 2023, unless renewed by appropriate 

action. The APOE was chartered under 

42 U.S.C. 217a, section 222 of the Public 

Health Service Act, as amended. The 

APOE is governed by provisions of 

Public Law 92–463, as amended (5 

U.S.C. Appendix 2), which sets forth 

standards for the formation and use of 

advisory committees. 

In accordance with the renewed 

charter, the APOE will advise the 

Secretary and the CMS Administrator 

concerning optimal strategies for the 

following: 

• Developing and implementing 

education and outreach programs for 

individuals enrolled in, or eligible for, 

Medicare, Medicaid, the CHIP, and 

coverage available through the Health 

Insurance Marketplace® and other CMS 

programs. 

• Enhancing the federal government’s 

effectiveness in informing Medicare, 

Medicaid, CHIP, or the Health Insurance 

Marketplace® consumers, issuers, 

providers, and stakeholders, pursuant to 

education and outreach programs of 

issues regarding these programs, 

including the appropriate use of publicprivate partnerships to leverage the 

resources of the private sector in 

educating beneficiaries, providers, 

partners and stakeholders. 

• Expanding outreach to vulnerable 

and underserved communities, 

including racial and ethnic minorities, 

in the context of Medicare, Medicaid, 

the CHIP and the Health Insurance 

Marketplace® education programs, and 

other CMS programs as designated. 

• Assembling and sharing an 

information base of ‘‘best practices’’ for 

helping consumers evaluate health 

coverage options. 

• Building and leveraging existing 

community infrastructures for 

information, counseling, and assistance. 

• Drawing the program link between 

outreach and education, promoting 

consumer understanding of health care 

coverage choices, and facilitating 

consumer selection/enrollment, which 

in turn support the overarching goal of 

improved access to quality care, 

including prevention services, 

envisioned under the Affordable Care 

Act. 

The current members of the Panel as 

of June 3, 2021, are: E. Lorraine Bell, 

Chief Officer, Population Health, 

Catholic Charities USA; Nazleen 

Bharmal, Medical Director of 

Community Partnerships, Cleveland 

Clinic; Julie Carter, Senior Federal 

Policy Associate, Medicare Rights 

Center; Scott Ferguson, Director of Care 

Transitions and Population Health, 

Mount Sinai St. Luke’s Hospital; Leslie 

Fried, Senior Director, Center for 

Benefits Access, National Council on 

Aging; Jean-Venable Robertson Goode, 

Professor, Department of 

Pharmacotherapy and Outcomes 

Science, School of Pharmacy, Virginia 

Commonwealth University; Ted 

Henson, Director of Health Center 

Performance and Innovation, National 

Association of Community Health 

Centers; Joan Ilardo, Director of 

Research Initiatives, Michigan State 

University, College of Human Medicine; 

Cheri Lattimer, Executive Director, 

National Transitions of Care Coalition; 

Cori McMahon, Vice President, 

Tridiuum; Alan Meade, Director of 

Rehabilitation Services, Holston 

Medical Group; Michael Minor, 

National Director, H.O.P.E. HHS 

Partnership, National Baptist 

Convention USA, Incorporated; Jina 

Ragland, Associate State Director of 

Advocacy and Outreach, AARP 

Nebraska; Morgan Reed, Executive 

Director, Association for Competitive 

Technology; Margot Savoy, Chair, 

Department of Family and Community 

Medicine, Temple University 

Physicians; Congresswoman Allyson 

Schwartz, President and CEO, Better 

Medicare Alliance; and; Tia Whitaker, 

Statewide Director, Outreach and 

Enrollment, Pennsylvania Association 

of Community Health Centers. 

II. Provisions of This Notice 

In accordance with section 10(a) of 

the FACA, this notice announces a 

meeting of the APOE. The agenda for 

the July 28, 2021 meeting will include 

the following: 

• Welcome and listening session with 

CMS leadership 

• Recap of the previous (May 26, 2021) 

meeting 

• CMS programs, initiatives, and 

priorities 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices 36751 

• An opportunity for public comment 

• Meeting summary, review of 

recommendations, and next steps 

Individuals or organizations that wish 

to make a 5-minute oral presentation on 

an agenda topic should submit a written 

copy of the oral presentation to the DFO 

at the address listed in the ADDRESSES

section of this notice by the date listed 

in the DATES section of this notice. The 

number of oral presentations may be 

limited by the time available. 

Individuals not wishing to make an oral 

presentation may submit written 

comments to the DFO at the address 

listed in the ADDRESSES section of this 

notice by the date listed in the DATES

section of this notice. 

III. Meeting Participation 

The meeting is open to the public, but 

attendance is limited to registered 

participants. Persons wishing to attend 

this meeting must register at the website 

https://www.eventbrite.com/e/apoe-july28-2021-virtual-meeting-tickets151112584809 or contact the DFO at the 

address or number listed in the FOR

FURTHER INFORMATION CONTACT section of 

this notice by the date specified in the 

DATES section of this notice. This 

meeting will be held virtually. 

Individuals who are not registered in 

advance will be unable to attend the 

meeting. 

IV. Collection of Information 

This document does not impose 

information collection requirements, 

that is, reporting, recordkeeping, or 

third-party disclosure requirements. 

Consequently, there is no need for 

review by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. Chapter 35). 

The Administrator of the Centers for 

Medicare & Medicaid Services (CMS), 

Chiquita Brooks-LaSure, having 

reviewed and approved this document, 

authorizes Lynette Wilson, who is the 

Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Dated: June 30, 2021. 

Lynette Wilson, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2021–14830 Filed 7–12–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–2567] 

Emergency Clearance: Public 

Information Collection Requirements 

Submitted to the Office of Management 

and Budget (OMB) 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is requesting 

that this information collection request 

(ICR), for revisions to the form CMS– 

2567 be processed under the emergency 

Paperwork Reduction Act of 1995 (PRA) 

clearance process. 

DATES: Comments must be received by 

August 12, 2021. 

ADDRESSES: When commenting, please 

reference the document identifier 

(CMS–2567) or OMB control number 

(0938–0391). To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: CMS–R–39/OMB Control 

Number 0938–0365, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

http://www.cms.hhs.gov/ 

PaperworkReductionActof1995. 

FOR FURTHER INFORMATION CONTACT: 

William Parham, Reports Clearance 

Office at (410) 786–1326. 

SUPPLEMENTARY INFORMATION: In 

December, 2020, Congress passed the 

Consolidated Appropriations Act, 2021 

(CAA, 2021). Section 407 of CAA, 2021, 

amended Part A of Title XVIII of the 

Social Security Act (the Act) at section 

1822 establishing hospice program 

survey and enforcement requirements. 

This amendment, in part, now requires 

the Accrediting Organizations (AOs) 

that accredit hospice programs to 

include the form CMS–2567 to 

document the findings of their hospice 

program surveys beginning on October 

1, 2021. Public harm is reasonably likely 

to ensue if the normal, non-emergency 

clearance procedures are followed. CMS 

would miss the statutorily mandated 

deadline of October 1, 2021 for 

Accrediting Organizations (AOs), with a 

hospice program, to begin using the 

form CMS–2567. AOs will not have the 

revised form to include in their current 

survey documentation systems and 

processes and will not meet the 

deadline of October 1, 2021 for 

beginning use. If CMS misses the 

deadline, it will jeopardize another 

CAA, 2021 mandated provision 

deadline for public posting of these AO 

hospice program survey reports on our 

website. The purpose of this 

requirement is for public transparency 

of survey and certification information. 

This statutory provision requires that 

the hospice program survey reports be 

posted by no later than October 1, 2022. 

Additionally, the public may not have 

all the information necessary to make an 

informed decision regarding where they 

seek high quality, safe care hospice 

program organizations for themselves or 

loved ones. Beneficiaries and the public 

at large utilize survey findings when 

evaluating whether to receive care from 

certain facilities. 

Under the PRA, federal agencies are 

required to publish notice in the 

Federal Register concerning each 

proposed ICR. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this ICR including the necessity and 

utility of the proposed ICR for the 

proper performance of the agency’s 

functions, the accuracy of the estimated 

burden, ways to enhance the quality, 

utility, and clarity of the information to 

be collected and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following ICR. More detailed 

information can be found in the 

collection’s supporting statement and 

associated materials (see ADDRESSES). 

CMS–2567 Statement of Deficiency 

and Plan of Correction 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 


jbell on DSKJLSW7X2PROD with NOTICES